Clinical cases of the drug-resistant fungus Candida auris rose over 50% from 2022 to 2023, with 4,514 cases reported across 36 US states and Washington, D.C., according to data reported to the CDC. This is a significant increase from 2,928 cases in 2022. C. auris poses a significant public health threat due to its resistance to multiple antifungal treatments and ability to rapidly spread in healthcare settings.
Nearly 250,000 Records From Tax Credit Consulting Agency Exposed
Summarize this content to a maximum of 60 words: Research has uncovered an unencrypted, non-password-protected database containing 245,949 records.
